Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma.

BACKGROUND: Due to improved treatment, more patients with multiple myeloma (MM) reach a state of minimal residual disease (MRD). Different strategies for MM MRD monitoring include flow cytometry, allele-specific oligonucleotide–quantitative PCR, next generation sequencing, and mass spectrometry (MS)...

Descripción completa

Detalles Bibliográficos

Publicado en:	Clinical Chemistry Vol. 67; no. 6; pp. 867 - 876
Autores principales:	Langerhorst, Pieter, Brinkman, Arie B., VanDuijn, Martijn M., Wessels, Hans J. C. T., Groenen, Patricia J. T. A., Joosten, Irma, van Gool, Alain J., Gloerich, Jolein, Scheijen, Blanca, Jacobs, Joannes F. M.
Formato:	Journal Article
Publicado:	Oxford University Press / USA Jun2021
Acceso en línea:	Ver este registro en EBSCOhost